Cite
Trocmé C, Gonnet N, Di Tommaso M, et al. Serum IRAP, a Novel Direct Biomarker of Prediabetes and Type 2 Diabetes?. Front Mol Biosci. 2021;7:596141doi: 10.3389/fmolb.2020.596141.
Trocmé, C., Gonnet, N., Di Tommaso, M., Samouda, H., Cracowski, J. L., Cracowski, C., Lambert-Porcheron, S., Laville, M., Nobécourt, E., Gaddhab, C., Le Lay, A., Bohn, T., Poitou, C., Clément, K., Al-Mulla, F., Bitar, M. S., & Bottari, S. P. (2020). Serum IRAP, a Novel Direct Biomarker of Prediabetes and Type 2 Diabetes?. Frontiers in molecular biosciences, 7596141. https://doi.org/10.3389/fmolb.2020.596141
Trocmé, Candice, et al. "Serum IRAP, a Novel Direct Biomarker of Prediabetes and Type 2 Diabetes?." Frontiers in molecular biosciences vol. 7 (2020): 596141. doi: https://doi.org/10.3389/fmolb.2020.596141
Trocmé C, Gonnet N, Di Tommaso M, Samouda H, Cracowski JL, Cracowski C, Lambert-Porcheron S, Laville M, Nobécourt E, Gaddhab C, Le Lay A, Bohn T, Poitou C, Clément K, Al-Mulla F, Bitar MS, Bottari SP. Serum IRAP, a Novel Direct Biomarker of Prediabetes and Type 2 Diabetes?. Front Mol Biosci. 2021 Feb 16;7:596141. doi: 10.3389/fmolb.2020.596141. eCollection 2020. PMID: 33665204; PMCID: PMC7921167.
Copy
Download .nbib